Office of Diversion Control, US Department of Justice, Drug Enforcement Administration

ABOUT US > What's New

What's New

July 2014

60-Day Notice - eComments Requested: Submission for OMB Approval: U.S. Official Order Forms—Schedules I & II (DEA Form 222) (July 17, 2014)

Meridian Medical Technologies (July 14, 2014)

Research Triangle Institute (July 14, 2014)

Moore Clinical Trials, L.L.C.; Decision and Order (July 11, 2014)

Research Triangle Institute (July 11, 2014)

S & B Pharma, Inc. (July 8, 2014)

Placement of Tramadol Into Schedule IV (July 2, 2014)

Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2015 (July 2, 2014)


June 2014

30-Day Notice - eComments Requested: Submission for OMB Approval (June 23, 2014)

30-Day Notice - eComments Requested: Submission for OMB Approval; ARCOS Transaction Reporting (June 23, 2014)

30-Day Notice - eComments Requested: Submission for OMB Approval; Application for Permit To Export Controlled Substances/Application for Permit To Export Controlled Substances for Subsequent Re-Export (June 23, 2014)

60-Day Notice - eComments Requested: Extension of a Previously Approved Collection Red Ribbon Week Patch (June 23, 2014)

Catalent CTS, LLC (June 17, 2014)

Alkermes Gainesville LLC (June 17, 2014)

Meda Pharmaceuticals, Inc. (June 17, 2014)

Cody Laboratories, Inc. (June 17, 2014)

Stepan Company (June 17, 2014)

Cedarburg Pharmaceuticals, Inc. (June 17, 2014)

AMPAC Fine Chemicals LLC (June 17, 2014)

Austin Pharma, LLC. (Correction) (June 17, 2014)

Euticals, Inc. (June 17, 2014)

Roy S. Schwartz; Decision and Order (June 16, 2014)

Proposed Adjustments to the Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2014 (June 12, 2014)

2014 Established Aggregate Production Quotas for 10 Temporarily Controlled Synthetic Cathinones (June 5, 2014)

Actavis Pharma, Inc. (June 4, 2014)

Penick Corporation (June 4, 2014)

Mylan Technologies, Inc. (June 4, 2014)

Akorn, Inc. (June 4, 2014)

Rhodes Technologies (June 4, 2014)

Arizona Department of Corrections (June 4, 2014)

Wildlife Laboratories, Inc. (June 4, 2014)

R & D Systems, Inc. (June 4, 2014)

SA INTL GMBH C/O., Sigma Aldrich Co., LLC. (June 4, 2014)

Stepan Company (June 4, 2014)

Lin Zhi International, Inc. (June 4, 2014)

Boehringer Ingelheim Chemical, Inc. (June 4, 2014)

Apertus Pharmaceuticals (June 4, 2014)

Austin Pharma, LLC. (June 4, 2014)

Cayman Chemical Company (June 4, 2014)

Noramco, Inc. (June 4, 2014)

Wildlife Laboratories, Inc. (June 3, 2014)

Alltech Associates, Inc. (June 3, 2014)

Hospira (June 3, 2014)

Mallinckrodt, LLC. (June 3, 2014)

Pharmacore, Inc. (June 3, 2014)

Cody Laboratories, Inc. (June 3, 2014)

Siegfried (USA), LLC (June 3, 2014)


May 2014

60-Day Notice - eComments Requested: Report of Theft or Loss of Controlled Substances (May 23, 2014)

60-Day Notice - eComments Requested: Controlled Substances Import/Export Declaration (May 23, 2014)

60-Day Notice - eComments Requested: Registrants Inventory of Drugs Surrendered (May 23, 2014)

60-Day Notice - eComments Requested: Reinstatement, With Change, of a Previously Approved Collection For Which Approval Has Expired: ARCOS Transaction Reporting (May 19, 2014)

30-Day Notice - eComments Requested: Self-Certification, Training, and Logbooks for Regulated Sellers of Scheduled Listed Chemical Products (May 16, 2014)

Stepan Company (May 15, 2014)

Siemens Healthcare Diagnostics, Inc. (May 15, 2014)

Alltech Associates, Inc. (May 15, 2014)

Notice with Request for Comments: Adjustment to the Established 2014 Aggregate Production Quota for Marijuana (Monday, May 5, 2014)

Kate B. Mayes, M.D.; Decision and Order (May 1, 2014)

Gregory White, M.D.; Decision and Order (May 1, 2014)


April 2014

Notice of Application with Opportunity for Comment: PCAS-Nanosyn, LLC (April 30, 2014)

2014 Established Aggregate Production Quotas for Four Temporarily Controlled Synthetic Cannabinoids (April 28, 2014)

Notice of Application with Opportunity for Comment: Patheon Pharmaceuticals, Inc. (April 28, 2014)

Notice of Application with Opportunity for Comment: Organix, Inc. (April 28, 2014)

Research Triangle Institute (April 28, 2014)

Almac Clinical Services, Inc., (ACSI) (April 28, 2014)

Meridian Medical Technologies (April 28, 2014)

S & B Pharma, Inc. (April 28, 2014)

Noramco, Inc. (April 28, 2014)

Myoderm (April 28, 2014)

Mylan Pharmaceuticals, Inc. (April 28, 2014)

American Radiolabeled Chemicals, Inc. (April 28, 2014)

60-Day Notice - eComments Requested: Reinstatement, With Change, of a Previously Approved Collection for Which Approval Has Expired: Dispensing Records of Individual Practitioners (April 18, 2014)

60-Day Notice - eComments Requested: Application for Permit To Export Controlled Substances/Export Controlled Substances for Re-Export; DEA Forms 161 and 161r (April 18, 2014)

60-Day Notice - eComments Requested: Reinstatement, With Change, of a Previously Approved Collection for Which Approval Has Expired: ARCOS Transaction Reporting (April 18, 2014)

Vincent G. Colosimo, D.M.D.; Decision and Order (April 14, 2014)

Howard N. Robinson, M.D.; Decision and Order (April 8, 2014)

Fred Samimi, M.D.; Decision and Order (April 3, 2014)

Mark P. Koch, D.O.; Decision and Order (April 3, 2014)

2014 Proposed Aggregate Production Quota for 10 Temporarily Controlled Synthetic Cathinones (April 1, 2014)

2014 Established Aggregate Production Quotas for Three Temporarily Controlled Synthetic Phenethylamines (April 1, 2014)


March 2014

30-Day Notice - eComments Requested: Drug Questionnaire; DEA Form 341 (March 28, 2014)

30-Day Notice - eComments Requested: Drug Questionnaire; DEA Form 341 (March 24, 2014)

Cerilliant Corporation (March 13, 2014)

GE Healthcare (March 13, 2014)

Siegfried USA, LLC (March 13, 2014)

Johnson Matthey, Inc. (March 13, 2014)

Cayman Chemical Company (March 13, 2014)

Johnson Matthey, Inc. (March 13, 2014)

Cedarburg Pharmaceuticals, Inc. (March 13, 2014)

Morton Grove Pharmaceuticals (March 13, 2014)

Stepan Company (March 13, 2014)

Research Triangle Institute (March 13, 2014)

Nektar Therapeutics (March 13, 2014)

Johnson Matthey, Inc. (March 13, 2014)

Pharmacore, Inc. (March 13, 2014)

Cambrex Charles City, Inc. (March 13, 2014)

GE Healthcare (March 13, 2014)

2014 Proposed Aggregate Production Quota for Four Temporarily Controlled Synthetic Cannabinoids (March 7, 2014)

Temporary Placement of 10 Synthetic Cathinones Into Schedule I (March 7, 2014)

60-Day Notice - Comments Requested: Self-Certification, Training, and Logbooks for Regulated Sellers of Scheduled Listed Chemical Products (March 6, 2014)


February 2014

Rescheduling of Hydrocodone Combination Products From Schedule III to Schedule II (February 27, 2014)

Placement of Alfaxalone into Schedule IV (February 27, 2014)

30-Day Notice - Comments Requested: Reports of Suspicious Orders or Theft/Loss of Listed Chemicals/Machines (February 18, 2014)

Placement of Suvorexant into Schedule IV (February 13, 2014)

Temporary Placement of Four Synthetic Cannabinoids Into Schedule I (February 10, 2014)

Catalent CTS, Inc. (February 7, 2014)

S & B Pharma, Inc. (February 4, 2014)

Research Triangle Institute (February 4, 2014)

Wildlife Laboratories, Inc. (February 4, 2014)

Penick Corporation (February 4, 2014)

Sigma Aldrich Research Biochemicals, Inc. (February 4, 2014)

Johnson Matthey Pharmaceutical Materials, Inc. (February 4, 2014)

Cambridge Isotope Lab (February 4, 2014)

Euticals, Inc. (February 4, 2014)

Cerilliant Corporation (February 4, 2014)


January 2014

2014 Proposed Aggregate Production Quota for Three Temporarily Controlled Synthetic Phenethylamines (January 30, 2014)

House of Medicine; Decision and Order (January 30, 2014)

Ralph J. Chambers, M.D.; Decision and Order (January 30, 2014)

United States Pharmacopeial Convention (January 30, 2014)

Cambrex Charles City, Inc. (January 30, 2014)

Clinical Supplies Management, Inc. (January 30, 2014)

Halo Pharmaceutical, Inc. (January 30, 2014)

Irix Manufacturing, Inc. (January 29, 2014)

Temporary Placement of 10 Synthetic Cathinones into Schedule I (January 28, 2014)

Roderick Lee Mitchell, M.D.; Decision and Order (January 22, 2014)

Noramco, Inc. (January 22, 2014)

Noramco, Inc. (January 22, 2014)

Noramco, Inc. (January 22, 2014)

60-Day Notice - Comments Requested: Drug Questionnaire; DEA Form 341 (January 21, 2014)

James Clopton, M.D.; Decision and Order (January 14, 2014)

Temporary Placement of Four Synthetic Cannabinoids Into Schedule I (January 10, 2014)

Siegfried USA, LLC. (January 10, 2014)

Myoderm (January 10, 2014)

Cody Laboratories, Inc. (January 10, 2014)

Fresenius Kabi USA, LLC. (January 10, 2014)

Mylan Pharmaceuticals, Inc. (January 10, 2014)

Fisher Clinical Services, Inc. (January 10, 2014)

Cayman Chemical Company (January 10, 2014)

Cody Laboratories, Inc. (January 10, 2014)

Organix, Inc. (January 10, 2014)

Cerilliant Corporation (January 8, 2014)

Noramco, Inc. (GA) (January 8, 2014)

Siegfried (USA), LLC (January 8, 2014)

Hospira (January 2, 2014)

American Radiolabeled Chemicals, Inc. (January 2, 2014)

Boehringer Ingelheim Chemicals, Inc.; Correction (January 2, 2014)


December 2013

New DEA Number Series (December 6, 2013)

60-Day Notice - Comments Requested: Reports of Suspicious Orders or Theft/Loss of Listed Chemicals/Machines (December 18, 2013)

Thomas Neuschatz, M.D.; Decision and Order (December 17, 2013)

Schedules of Controlled Substances: Placement of Perampanel into Schedule III (December 2, 2013)

Emergency Disaster Relief
Got Drugs? Turn in your unused or expired medication for safe disposal here.
Alert! Extortion Scam

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Office of Diversion Control  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539